Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Ampullary Adenocarcinoma × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 1619 Neoplasms 1361 Carcinoma, Non-Small-Cell Lung 940 Prostatic Neoplasms 870 Colorectal Neoplasms 784 Lung Neoplasms 717 Pancreatic Neoplasms 533 Carcinoma, Hepatocellular 488 Leukemia, Myeloid, Acute 476 Stomach Neoplasms 461 Ovarian Neoplasms 454 Neoplasm Metastasis 437 Multiple Myeloma 434 Recurrence 367 Melanoma 355 Uterine Cervical Neoplasms 333 Squamous Cell Carcinoma of Head and Neck 324 Head and Neck Neoplasms 321 Brain Neoplasms 316 Esophageal Neoplasms 301 Lymphoma 293 Precursor Cell Lymphoblastic Leukemia-Lymphoma 284 Endometrial Neoplasms 279 Triple Negative Breast Neoplasms 264 Rectal Neoplasms 261 Glioblastoma 256 Urinary Bladder Neoplasms 250 Sarcoma 239 Hematologic Neoplasms 236 Carcinoma, Renal Cell 235

Interventions

folfirinox 1 Oxaliplatin 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06068023 2023-10-05

ADAPTA

Fondazione Poliambulanza Istituto Ospedaliero

Ampullary Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡